NUTM2A and hepatocellular carcinoma: NUTM2A-AS1 was found to be highly expressed and linked to the prognosis and prognosis in gastric cancer, non-small cell lung carcinoma, hepatocellular carcinoma, suggesting its potential role in other cancers [25–27].